Thalidomide-O-C4-NH2 (hydrochloride), 100mg

9,9-Dimethyl-9,10-dihydroacridine, 95.0%, 1g

3-Benzyl-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide, 99+%, 1g

Ethyl 3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 5g

1-Benzyl-4-((5,6-dimethoxy-1H-inden-2-yl)methyl)piperidine, 97%, 1mg

4-Iodo-3-methylbenzonitrile, 95+%, 10g

Saponin, DAB, 25 g, plastic packaging.

Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate, 95.0%, 1g

1-Bromo-2-iodo-4-(trifluoromethoxy)benzene, 97%, 25g

tert-butyl 3-{[2-(1H-indol-3-yl)ethyl]amino}propanoate, 95.0%, 10g

(1R)-1-(4-BROMO-2-CHLOROPHENYL)ETHAN-1-AMINE HYDROCHLORIDE, 95%, 100mg

4-(Bromomethyl)-2-quinolinone>97.0%(HPLC)(N)5g

N-Carbobenzoxy-beta-alanine>98.0%(T)10g